CHEMED CORP (CHE) Stock Analyst Ratings

NYSE:CHE • US16359R1032

477.19 USD
+2.38 (+0.5%)
Last: Feb 23, 2026, 12:36 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to CHE. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 566.61. This target is 18.74% above the current price.
  • CHE was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CHE.
  • In the last month the buy percentage fell by 5 points. So the trust of analysts is decreasing.
  • CHE was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
CHE Historical Analyst RatingsCHE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Price Target & Forecast

Price Low Median Mean High 477.19479.75587.52566.61624.75 - 0.54% 23.12% 18.74% 30.92%

Related screens

Find peers 30% below price target
CHE Current Analyst RatingCHE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2026-01-22 Jefferies Downgrade Buy -> Hold
2025-11-10 RBC Capital Maintains Outperform -> Outperform
2025-09-10 B of A Securities Maintains Buy -> Buy
2025-09-02 Jefferies Upgrade Hold -> Buy
2025-07-31 Oppenheimer Maintains Outperform -> Outperform
2025-07-31 RBC Capital Maintains Outperform -> Outperform
2025-07-25 Jefferies Initiate Hold
2025-06-30 RBC Capital Maintains Outperform -> Outperform
2025-06-30 B of A Securities Maintains Buy -> Buy
2025-04-28 RBC Capital Maintains Outperform -> Outperform
2025-03-14 RBC Capital Maintains Outperform -> Outperform
2024-11-05 RBC Capital Maintains Outperform -> Outperform
2024-05-21 RBC Capital Maintains Outperform -> Outperform
2024-03-04 RBC Capital Maintains Outperform -> Outperform
2024-02-29 Oppenheimer Maintains Outperform -> Outperform
2024-01-17 Oppenheimer Maintains Outperform -> Outperform
2023-10-30 RBC Capital Maintains Outperform -> Outperform
2023-07-31 RBC Capital Maintains Outperform -> Outperform
2023-07-27 Oppenheimer Maintains Outperform -> Outperform
2023-05-01 RBC Capital Maintains Outperform
2023-04-28 Oppenheimer Maintains Outperform
2023-02-27 RBC Capital Maintains Outperform
2022-11-03 RBC Capital Maintains Outperform
2022-08-01 RBC Capital Maintains Outperform
2022-04-28 RBC Capital Maintains Outperform
2022-03-04 RBC Capital Maintains Outperform
2021-07-29 RBC Capital Maintains Outperform
2021-02-25 Oppenheimer Maintains Outperform

CHEMED CORP / CHE FAQ

What is the price target for CHE stock?

8 analysts have analysed CHE and the average price target is 566.61 USD. This implies a price increase of 18.74% is expected in the next year compared to the current price of 477.19.


What is the consensus rating for CHEMED CORP (CHE) stock?

The consensus rating for CHEMED CORP (CHE) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.


What is the number of analysts for CHE stock?

The number of analysts covering CHEMED CORP (CHE) is 8.